PLSE
PLSE clinical trials: PULSE BIOSCIENCES, INC.
Every trial on ClinicalTrials.gov where PULSE BIOSCIENCES, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 15
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
PLSE on the catalyst calendar · PLSE registry changes
- Primary completion Nov 30, 2027Sponsor estimateNo phase registeredNCT07912892Treating PHPT With the nPulse™ Vybrance™ PE SystemPulse Biosciences, Inc. · Primary HyperparathyroidismNot yet recruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2027Sponsor estimateNo phase registeredNCT07287176Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemPulse Biosciences, Inc. · Thyroid NoduleActive, not recruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimateNo phase registeredNCT06959121CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationPulse Biosciences, Inc. · Atrial FibrillationRecruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimateNo phase registeredNCT07018596NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX SystemPulse Biosciences, Inc. · Atrial Fibrillation ParoxysmalRecruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 25, 2026Sponsor estimateNo phase registeredNCT06696170CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial FibrillationPulse Biosciences, Inc. · Atrial Fibrillation ParoxysmalRecruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT06355063CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial FibrillationPulse Biosciences, Inc. · Atrial FibrillationRecruitingPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 18, 2024ActualNo phase registeredNCT06117085CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid NodulesPulse Biosciences, Inc. · Thyroid Nodule (Benign)CompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 5, 2018ActualNo phase registeredNCT03612570Nano-Pulse Stimulation (NPS) in Sebaceous HyperplasiaPulse Biosciences, Inc. · Skin LesionCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2, 2021ActualNo phase registeredNCT04539886Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) LesionsPulse Biosciences, Inc. · Skin LesionCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2021ActualNo phase registeredNCT04738734CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common WartsPulse Biosciences, Inc. · WartsCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 14, 2020ActualNo phase registeredNCT04253418Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization StudyPulse Biosciences, Inc. · Sebaceous HyperplasiaTerminatedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 13, 2020ActualNo phase registeredNCT04249115Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization StudyPulse Biosciences, Inc. · Lesion SkinTerminatedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2017ActualNo phase registeredNCT03846531Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis StudyPulse Biosciences, Inc. · Lesion SkinCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 9, 2020ActualNo phase registeredNCT04554394CellFX System for the Treatment of Cutaneous Non-Genital WartsPulse Biosciences, Inc. · WartsCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2, 2022ActualNo phase registeredNCT04918381CellFX Treat & Resect Low-Risk BCC Feasibility StudyPulse Biosciences, Inc. · BCC - Basal Cell CarcinomaCompletedPLSELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner